Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

M.D. Anderson Cancer Center50 enrolled

Overview

To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.

Primary Objectives • To evaluate thyroid nodule volume changes over time in participants undergoing RFA as part of clinical care Secondary Objectives * To establish the health-related quality of life among participants undergoing with ultrasound guided RFA. * To evaluate the sonographic features of thyroid nodules over time following ultrasound guided RFA. * To assess adverse events rates following ultrasound guided RFA.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Low Risk Papillary Thyroid Cancer Radiofrequency Ablation

Interventions

QuestionnaireOTHER

This questionnaire includes twenty-four questions covering patients complaints ranging from 0 to 4. Patients will be asked about the presence and severity of each item currently on the medical appointment.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Eligibility Criteria 1. Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC 2. Participant is over 18 years and is either not a surgical candidate or has declined surgery. 3. Capable and willing to provide written informed consent 4. Participant has one of the following diagnoses: * Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment, * Biopsy-proven indeterminate nodules (AUS or follicular neoplasm) * Papillary thyroid carcinoma (PTC) without metastasis * Locally recurrent thyroid cancer (\< 2 cm). Exclusion Criteria 1. Participants meeting any of the following criteria will be excluded: 2. Participants considered unsuitable for RFA by the treating physician

Locations (1)

MD Anderson Cancer Center

Houston, Texas, United States

RECRUITING

Outcomes

Primary Outcomes

Health- related Quality of Life Questionnaires

Time frame: Through study completion; an average of 1 year

Central Contacts

Victoria E Banuchi, MD

CONTACT

346-217-8668 vebanuchi@mdanderson.org

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.